Biofit Fostering Innovation & Transfer
With more than 1,300 international actors from tech transfer offices (TTOs), research institutes, and academia, together with big pharma, emerging and small biotech, diagnostic companies, veterinary firms, and pre-seed/seed/Series A investors, BioFIT has become the leading partnering event in Europe for technology transfer, academia-industry collaborations, early-stage innovation deals, and the European marketplace for early-stage financing rounds in the Life Sciences field. The event is, above all, an optimal business convention with prequalified one-on-one meetings. Its online platform allows participants to identify potential partners, to pre-schedule meetings with them, and to meet them during the event, in order to build partnerships. During the last edition, over 13,000 meetings had been generated through the partnering system.
In addition to the one-on-one meetings, BioFIT offers pitch sessions that give the opportunity to detect the most innovative start-ups and promising collaborative and licensing opportunities, in order to foster partnerships and business development in the Life Sciences field. It is also a great opportunity for bioentrepreneurs to showcase in front of potential partners. The session entitled “Start-up Slams” are dedicated to start-ups seeking to raise a seed or Series A financing round, whereas the “Collaborative and Licensing Opportunity Presentations” are devoted to TTOs, universities, research institutes, and companies willing to promote an early-stage asset.
Furthermore, BioFIT offers its participants a “Would-Be CEO” session. This session aims to bring together start-ups, incubators, TTOs, scientific founders, and would-be CEOs, and allows bioentrepreneurs seeking a project to lead, to find new companies or those in process of being created, or to become involved as a CEO. This Would-Be CEO session also allows projects in need of CEOs to find their future leaders.